Delenex Therapeutics
Z├╝rich · Founded 2009
About Delenex Therapeutics
Delenex Therapeutics is engaged in developing therapeutic antibody fragments for diseases with high unmet needs.
Company Facts
- Founded: 2009
- Legal name: Delenex Therapeutics AG
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $41.3M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2016)
- Website: delenex.com
- Phone: 41 44 730 51 80
Social Profiles
Canonical: https://fsome.com/organization/delenex-therapeutics-8333087 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.